BioSpace News Archive

AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center announced they have entered into a collaboration to develop a novel antibody therapeutic to prevent and treat COVID-19, the pandemic respiratory disease caused by the SARS-CoV-2 virus.

Eviana Health Corporation is pleased to announce the appointment of J. Scott Munro to the position of interim Chief Financial Officer.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced it has resumed its pivotal study of Omnipod, Powered by Horizon™, the Company’s personal smart-phone controlled automated insulin delivery system.

Tetra Bio-Pharma Inc. are pleased to announce that they have finalized a definitive commercial sales agreement for the sale of the Mighty Medic device as part of the CAUMZ™-kit drug-device combination product.

TAG, Inc., formerly The Audit Group, helped healthcare systems recoup over $4,000,000 during the first month of the COVID-19 Pay-it-Forward Recovery Program.

RECARBRIO is Indicated to Treat Multiple Infections Caused by Susceptible Gram-Negative Bacteria in Adults

Transparency Market Research has published a new report on the home blood pressure monitoring devices market for the forecast period of 2019–2027.

Transparency Market Research has published a new report titled, “Hemorrhoid Treatment Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

Microbix Biosystems Inc., an award-winning life sciences innovator and exporter, is pleased to announce the attainment of European Union “CE mark” registration for its SARS-CoV-2 quality assessment products – CE mark registration enables Microbix’s network of distributors that now covers 18 EU countries to immediately begin providing these products to clinical laboratories across the EU.

Catheter stabilization devices is made to hold the catheter in place securely. These devices avert backflow of urine.